Status:
COMPLETED
Adaptive Pet Study
Lead Sponsor:
Duke University
Conditions:
Head and Neck Cancers
Lung and Esophagus Cancers
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
The purpose of this study is to determine the benefit of using positron emission tomography (PET) in addition to the standard (computed tomography) CT to plan radiation therapy for cancer treatment. T...
Eligibility Criteria
Inclusion
- Pathologically (histologically or cytologically) proven diagnosis of carcinoma
- Patients with local or regional nodal disease are eligible.
- Zubrod Performance Status 0, 1, or 2.
- Age ≥ 18
- Negative serum pregnancy test for women of child bearing potential
- Patient must sign study-specific informed consent prior to study entry.
Exclusion
- No gross disease visible on imaging at the start of radiotherapy
- Contraindication to PET
- Complete response by PET achieved with pre-radiation therapy treatment (surgery or chemotherapy)
- Breast feeding
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2016
Estimated Enrollment :
271 Patients enrolled
Trial Details
Trial ID
NCT01908504
Start Date
January 1 2012
End Date
September 1 2016
Last Update
April 26 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke University Medical Center
Durham, North Carolina, United States, 27710